Health Technology Assessment of the Role of Human Pampillomavirus Vaccines in Reducing the Risk of Cervical Cancer in Ireland

In July 2007, the Health Information and Quality Authority agreed to carry out a health technology assessment (HTA) on the role of vaccination against human papillomavirus (HPV) in reducing the risk of cervical cancer in Ireland in response to a request by the National Cancer Screening Service Board.

The purpose of this assessment was to establish the cost-effectiveness of a combined national HPV vaccination and cervical cancer screening programme compared to a cervical cancer screening programme alone in the prevention of cervical dysplasia (the condition that can lead to cervical cancer) and cervical cancer due to HPV types 16 and 18 in Ireland.

HTA_HPV_Full_report.pdf